The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Phase III study of taselisib (GDC-0032) + fulvestrant (FULV) v FULV in patients (pts) with estrogen receptor (ER)-positive, PIK3CA-mutant (MUT), locally advanced or metastatic breast cancer (MBC): Primary analysis from SANDPIPER.
 
Jose Baselga
Leadership - Infinity Pharmaceuticals; Varian Medical Systems
Stock and Other Ownership Interests - GRAIL; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma; Varian Medical Systems
Consulting or Advisory Role - GRAIL; Lilly; Novartis
 
Susan Faye Dent
Honoraria - amgen; Eisai; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche Canada
 
Javier Cortés
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Eisai; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Biothera; Celgene; Cellestia Biotech; Merus; Roche
 
Young-Hyuck Im
No Relationships to Disclose
 
Véronique Diéras
Consulting or Advisory Role - Abbvie; Lilly; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; Roche
 
Nadia Harbeck
Honoraria - Amgen; Celgene; Genomic Health; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - Celgene; Daiichi Sankyo; Lilly; Novartis; Pfizer; Roche/Genentech; Sandoz
Research Funding - Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Ian E. Krop
Consulting or Advisory Role - Genentech/Roche; Macrogenics
Research Funding - Genentech/Roche
 
Sunil Verma
Leadership - Oncology Education
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Merck; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Lilly; Novartis; Pfizer; Roche/Genentech; Spectrum Pharmaceuticals
 
Timothy R. Wilson
Employment - Genentech
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Genentech
 
Huan Jin
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Lijia Wang
Employment - Genentech
 
Frauke Schimmoller
Employment - Genentech
Stock and Other Ownership Interests - Exelixis; Merck; Roche; Teva
Patents, Royalties, Other Intellectual Property - Exelixis; Exelixis (Inst)
 
Jerry Y. Hsu
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Jing He
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Michelino DeLaurentiis
Honoraria - AstraZeneca; Celgene; Eisai; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Novartis; Roche
 
Pamela Drullinsky
No Relationships to Disclose
 
William Jacot
Honoraria - Pierre Fabre
Consulting or Advisory Role - Pfizer; Roche
Research Funding - AstraZeneca (Inst)